Median is a disrupter in the area of medical imaging analysis. Find out more about what we are doing and how our technology works.


Decentralized Clinical Trials: The patient-centric future of oncology R&D?

Full or Hybrid DCT? What is the best fit when it comes to oncology research, the role of clinical trial imaging with these models, and how do you ensure success? Watch this webinar replay to gain insight into DCT strategies and tools to consider for your next oncology trial.


  • Business Intelligence-based reporting optimizes the operational efficiency of clinical trial imaging services

    Business Intelligence (BI) is the combination of business analytics, data mining, data visualization, data tools and infrastructure, and best practices, which together can transform data into actionable insights that inform an organization’s business decisions . As an imaging CRO, Median uses Business Intelligence tools to streamline operations and provide a superior level of project management […]

    Read in full

    Median's Online Reporting Tool


Introducing Median Imaging Lab

Scientific publications

ECR 2023 | AIX Theater

iBiopsy® AI-powered software for lung cancer screening deployment at scale

Empowering radiologists for swift & accurate diagnosis

Case studies

How automation can improve data consistency/value, and streamline study workflow

White papers

Understanding Novel Response Patterns of Immunotherapies

Our unique solutions for medical image analysis and management and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy.